General Biologicals

General Biologicals EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of General Biologicals (4117.TWO) as of Oct 31, 2026 is -9.34. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -1.78 — a change of 424.05% (lower).

EV/FCF

-9.34

YoY

424.05%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of General Biologicals is 2025 -9.34 . EV/FCF (Enterprise Value to Free Cash Flow) of General Biologicals was 2024 -1.78 . It decreases by 424.05% lower compared to the previous year.

The General Biologicals EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-16.82 TWD
Jan 1, 2019
-326.27 TWD
Jan 1, 2020
21.81 TWD
Jan 1, 2021
-11.01 TWD
Jan 1, 2022
-41.51 TWD
Jan 1, 2023
-5.98 TWD
Jan 1, 2024
-1.78 TWD
Jan 1, 2025
-9.34 TWD
The General Biologicals EV/FCF history
YEAREV/FCFYoY
-9.34+424.05%
-1.78-70.23%
-5.98-85.58%
-41.51+277.15%
-11.01-150.46%
21.81-106.68%
-326.27+1,840.24%
-16.82+29.81%
-12.95+19.27%
-10.86-18.56%
-13.34-31.87%
-19.58—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

General Biologicals Stock analysis

What does General Biologicals do? General Biologicals Corp., headquartered in Baoshan, Hsinchu, Taiwan, operates in the Health Care sector, specifically within the Biotechnology industry. The company engages in research, development, manufacturing, and trading of diagnostics, pharmaceuticals, and medical supplies. Its main products include detection reagents, biological protein new drugs, P113, and medical supplies, distributed domestically and internationally. Listed on 4 July 2002, the company employs 63 people. General Biologicals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about General Biologicals stock

EV/FCF (Enterprise Value to Free Cash Flow) of General Biologicals is -9.34 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of General Biologicals changed from -1.78 to -9.34, representing a 424.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) General Biologicals since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s General Biologicals with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — General Biologicals

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — General Biologicals